Cover Image
市場調查報告書

聽力損失:主要12個國家的市場預測 (2017∼2027年)

Epiomic Epidemiology Series: Hearing Loss Forecast in 12 Major Markets 2017-2027

出版商 Black Swan Analysis 商品編碼 453822
出版日期 內容資訊 英文 48 Pages
訂單完成後即時交付
價格
Back to Top
聽力損失:主要12個國家的市場預測 (2017∼2027年) Epiomic Epidemiology Series: Hearing Loss Forecast in 12 Major Markets 2017-2027
出版日期: 2017年02月01日 內容資訊: 英文 48 Pages
簡介

本報告提供全球主要12個國家的聽覺損失的發病情形相關分析,疾病概要和目前的患病人數,各子類型及性別、各年代 (5歲區分) 的詳細情況,各地區、各民族的傾向,風險要素,疾病診斷與預後,主要的症狀和併發症 (暈眩,耳鳴,聽覺過敏,憂鬱症),未來趨勢預測 (今後10年份)等資訊彙整,為您概述為以下內容。

目錄

  • 圖表一覽
  • 簡介
  • 疾病的原因
  • 風險要素與預防法
  • 疾病診斷方法
  • 各地區/各民族的差異
  • 疾病的預後和臨床過程
  • 疾病相關的主要共生病症/特徵
  • 患者數的測量方法
  • 聽覺損失的最大患病人數
  • 聽覺損失患者的特徵
  • 在聽覺損失患者之間的助聽器的使用概況
  • 聽覺損失患者的併發症
  • 文中的簡稱一覽
  • Black Swan Analysis的其他出版刊物
  • Black Swan Analysis的線上、病患人數的資料庫
  • 病患人數的服務
  • 線上價格資料/平台
  • 參考文獻
  • 附錄

表格一覽

分析觀察對象國家

  • 巴西
  • 加拿大
  • 中國
  • 法國
  • 德國
  • 印度
  • 義大利
  • 日本
  • 俄羅斯
  • 西班牙
  • 英國
  • 美國

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: HRLS0010217

Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Hearing Loss in 12 Major Markets

Hearing loss results from pathologic conditions that affect the hearing pathway. These can be classed as conductive, sensorineural or mixed.

Conductive hearing loss occurs when something blocks the sound from reaching the inner ear whilst sensorineural hearing loss is when sound reaches the inner ear but either fails to be translated into nerve impulses (sensory loss), or the nerve impulses are not translated to the brain (neural loss).

It should be noted that hearing loss can be temporary in some instances, such as conductive hearing loss due to infection. Hearing loss can occur in one (bilateral) or both (unilateral) ears.

This report provides the current prevalent population for Hearing Loss across 12 Major Markets (USA, Canada, France, Germany, Russia, Italy, Spain, UK, Brazil, Japan, India and China) split by gender and 5-year age cohort. Along with the current prevalence, the report also contains a disease overview of the risk factors, disease diagnosis and prognosis along with specific variations by geography and ethnicity.

Providing a value-added level of insight from the analysis team at Black Swan, several of the main symptoms and co-morbidities of Hearing Loss have been quantified and presented alongside the overall prevalence figures. These sub-populations within the main disease are also included at a country level across the 10-year forecast snapshot.

Main symptoms and co-morbidities for Hearing Loss include:

  • Vertigo
  • Tinnitus
  • Hyperacusis
  • Depression

This report is built using data and information sourced from the proprietary Epiomic patient segmentation database. To generate accurate patient population estimates, the Epiomic database utilises a combination of several world class sources that deliver the most up to date information form patient registries, clinical trials and epidemiology studies. All of the sources used to generate the data and analysis have been identified in the report.

Reason to buy

  • Able to quantify patient populations in global Hearing Loss market to target the development of future products, pricing strategies and launch plans.
  • Gain further insight into the prevalence of the subdivided types of Hearing Loss and identify patient segments with high potential.
  • Delivery of more accurate information for clinical trials in study sizing and realistic patient recruitment for various countries.
  • Provide a level of understanding on the impact from specific co-morbid conditions on Hearing Loss prevalent population.
  • Identify sub-populations within Hearing Loss which require treatment.
  • Gain an understanding of the specific markets that have the largest number of Hearing Loss patients.

Table of Contents

  • List of Tables and Figures
  • Introduction
  • Cause of the Disease
  • Risk Factors & Prevention
  • Diagnosis of the Disease
  • Variation by Geography/Ethnicity
  • Disease Prognosis & Clinical Course
  • Key comorbid conditions/Features associated with the disease
  • Methodology for quantification of patient numbers
  • Top-line prevalence for Hearing Loss
  • Features of Hearing Loss patients
  • Hearing aid use within patients with Hearing Loss
  • Comorbidities among patients with Hearing Loss
  • Abbreviations used in the report
  • Other Black Swan Analysis Publications
  • Black Swan Analysis Online Patient-Based Databases
  • Patient-Based Offering
  • Online Pricing Data and Platforms
  • References
  • Appendix

List of Tables

  • WHO criteria of Hearing Impairment
  • Prevalence of Hearing Loss, total (000s)
  • Prevalence of Hearing Loss, males (000s)
  • Prevalence of Hearing Loss, females (000s)
  • Ears Impaired, total (000s)
  • Severity of impairment, total (000s)
  • Smoking status of patients with hearing loss, total (000s)
  • Hearing aid use, total (000s)
  • Hearing Aid treatment, total (000s)
  • Perceived level of hearing impairment, total (000s)
  • Hearing loss patients with diabetes, total (000s)
  • Hearing loss patients with hypertension, total (000s)
  • Hearing Loss patients with vision impairment, total (000s)
  • Abbreviations and Acronyms used in the report
  • USA Prevalence of Hearing Loss by 5-yr age cohort, males (000s)
  • USA Prevalence of Hearing Loss by 5-yr age cohort, females (000s)
  • Canada Prevalence of Hearing Loss by 5-yr age cohort, males (000s)
  • Canada Prevalence of Hearing Loss by 5-yr age cohort, females (000s)
  • France Prevalence of Hearing Loss by 5-yr age cohort, males (000s)
  • France Prevalence of Hearing Loss by 5-yr age cohort, females (000s)
  • Germany Prevalence of Hearing Loss by 5-yr age cohort, males (000s)
  • Germany Prevalence of Hearing Loss by 5-yr age cohort, females (000s)
  • Italy Prevalence of Hearing Loss by 5-yr age cohort, males (000s)
  • Italy Prevalence of Hearing Loss by 5-yr age cohort, females (000s)
  • Spain Prevalence of Hearing Loss by 5-yr age cohort, males (000s)
  • Spain Prevalence of Hearing Loss by 5-yr age cohort, females (000s)
  • UK Prevalence of Hearing Loss by 5-yr age cohort, males (000s)
  • UK Prevalence of Hearing Loss by 5-yr age cohort, females (000s)
  • Brazil Prevalence of Hearing Loss by 5-yr age cohort, males (000s)
  • Brazil Prevalence of Hearing Loss by 5-yr age cohort, females (000s)
  • Japan Prevalence of Hearing Loss by 5-yr age cohort, males (000s)
  • Japan Prevalence of Hearing Loss by 5-yr age cohort, females (000s)
  • India Prevalence of Hearing Loss by 5-yr age cohort, males (000s)
  • India Prevalence of Hearing Loss by 5-yr age cohort, females (000s)
  • China Prevalence of Hearing Loss by 5-yr age cohort, males (000s)
  • China Prevalence of Hearing Loss by 5-yr age cohort, females (000s)
  • Russia Prevalence of Hearing Loss by 5-yr age cohort, males (000s)
  • Russia Prevalence of Hearing Loss by 5-yr age cohort, females (000s)
Back to Top